The Effect of Atorvastatin on Patients with Kidney Stones

The Effect of Atorvastatin on the Prediction of 24-hour urinary Metabolic Indices in Patients with Kidney Stones: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260430069214N1

Enrollment

140

Registered

2026-05-08

Start date

2026-06-05

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus of kidney. Calculus of kidney

Interventions

Intervention 1: Intervention group: The intervention group will receive atorvastatin for 3 months in addition to standard treatment. Nutritional education will be provided to all patients, including d

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Stone size up to 6 mm (due to a similar likelihood of spontaneous passage up to 80%) No history of diabetes or cardiovascular diseases No chronic kidney disease

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
24-hour urinary metabolic indices. Timepoint: Before and immediately after the end of the intervention. Method of measurement: Using laboratory kits and standard laboratory methods.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mousavi

Yasouj University of Medical Sciences

seyedabolfazlmousavi1998@gmail.com+98 74 3323 5153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026